SWMRX Performance — Schwab Target 2045 Fund
Data updated: 2026-09-24
SWMRX returned +9.07% year to date and +18.69% over one year to Jul 2026. Annualised returns are +15.03% over 3 years and +8.05% over 5 years. The fund beat its Target-Date category average: $100 invested three years ago grew to $152, against $146 for the category, and to $119 over one year, against $116. Volatility over the past three years was 11.37% a year. In the 12 months to Jul 2026 the fund lost a net $57.9M, and assets reached $328.94M.
SWMRX Growth of $100
What $100 invested in Schwab Target 2045 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | SWMRX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $119 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $152 | $146 |
| 5 years (Aug 2021 – Jul 2026) | $147 | $142 |
| Since data start (Aug 2019 – Jul 2026) | $205 | $186 |
SWMRX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +9.07% |
| 1 year | +18.69% |
| 3 years (annualised) | +15.03% |
| 5 years (annualised) | +8.05% |
SWMRX Annual Returns
Calendar-year total returns of Schwab Target 2045 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +9.07% |
| 2025 | +18.87% |
| 2024 | +13.40% |
| 2023 | +20.08% |
| 2022 | −19.35% |
| 2021 | +16.87% |
| 2020 | +14.93% |
| 2019 (Aug–Dec) | +7.33% |
SWMRX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.8% | +1.9% | −6.0% | +7.7% | +3.6% | 0.0% | −0.8% | — | — | — | — | — |
| 2025 | +3.1% | −0.3% | −3.3% | +0.6% | +4.5% | +4.1% | +0.4% | +2.9% | +2.9% | +1.6% | +0.4% | +0.7% |
| 2024 | 0.0% | +3.9% | +2.9% | −3.8% | +4.3% | +1.4% | +2.1% | +2.3% | +1.6% | −2.2% | +3.8% | −3.1% |
| 2023 | +7.4% | −2.7% | +2.2% | +1.0% | −0.9% | +5.3% | +3.0% | −2.4% | −4.3% | −3.0% | +8.5% | +5.3% |
| 2022 | −5.1% | −3.0% | +1.2% | −7.5% | +0.3% | −7.9% | +6.9% | −4.2% | −9.2% | +5.9% | +7.4% | −4.1% |
| 2021 | −0.4% | +2.6% | +2.2% | +4.3% | +1.3% | +1.4% | +0.9% | +2.2% | −4.0% | +4.2% | −2.3% | +3.5% |
| 2020 | −1.1% | −6.4% | −14.0% | +10.4% | +4.8% | +3.0% | +4.7% | +5.0% | −2.6% | −1.8% | +10.4% | +4.4% |
| 2019 | — | — | — | — | — | — | — | −1.8% | +1.4% | +2.3% | +2.5% | +2.9% |
SWMRX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 11.37%
- 3-year Sharpe ratio: 0.93 (vs 4.5% risk-free rate)
- Best month: +8.46% (Nov 2023)
- Worst month: −5.96% (Mar 2026)
SWMRX Fund Flows
Monthly money in and out of Schwab Target 2045 Fund, from SEC Form N-PORT.
- 12-month net flow: −$57.9M
- 12-month gross sales (incl. reinvestments): $66.9M
- Sales ÷ redemptions: 0.54×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $3.1M | $4.2M | −$1.1M |
| Jun 2026 | $3.2M | $3.0M | $290K |
| May 2026 | $3.1M | $80.1M | −$77.0M |
| Apr 2026 | $3.6M | $3.2M | $465K |
| Mar 2026 | $4.1M | $4.3M | −$167K |
| Feb 2026 | $6.1M | $2.7M | $3.4M |
| Jan 2026 | $4.5M | $4.8M | −$284K |
| Dec 2025 | $22.1M | $5.1M | $17.0M |
| Nov 2025 | $2.8M | $2.6M | $184K |
| Oct 2025 | $5.2M | $4.7M | $575K |
| Sep 2025 | $3.6M | $4.7M | −$1.1M |
| Aug 2025 | $5.3M | $5.5M | −$136K |
SWMRX Assets Under Management
Net assets of Schwab Target 2045 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $328.94M |
| 2026-04-30 | $396.52M |
| 2026-01-31 | $380.51M |
| 2025-10-31 | $367.17M |
| 2025-07-31 | $341.92M |
| 2025-04-30 | $309.36M |
| 2025-01-31 | $320.03M |
| 2024-10-31 | $304.18M |
| 2024-07-31 | $296.08M |
| 2024-04-30 | $274.08M |
| 2024-01-31 | $265.56M |
| 2023-10-31 | $234.16M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.